Assoc. Prof. Dr. Fahad Sabei | Jazan universe | Saudi Arabia
Dr. Fahad Y. Sabei is a distinguished academic and researcher serving as an Associate Professor at the College of Pharmacy, Jazan University, Saudi Arabia. With advanced training in pharmaceutical sciences from renowned institutions in the United States and Saudi Arabia, he has built a strong interdisciplinary background spanning molecular biology, drug formulation, and nanotechnology-focused cancer therapeutics. Dr. Sabei’s expertise centers on the design and development of polymeric nanoparticles for both imaging and targeted treatment applications. His work integrates cutting-edge molecular techniques with innovative drug-delivery systems, contributing to advancements in cancer diagnosis and therapy. He is proficient in a wide spectrum of laboratory and research methodologies, including PCR, qPCR, RNA extraction, cell culture, and animal cancer models, complemented by experience with imaging tools such as ultrasound, photoacoustic systems, and Pearl imaging platforms. His technical capabilities are supported by strong data analysis and visualization skills using software such as GraphPad Prism and ChemBioDraw. At Jazan University, Dr. Sabei plays a key role in academic development, student mentoring, and research supervision. He has been an active contributor to institutional committees, including academic affairs, performance indicators, quality initiatives, community service, SPLE committee activities, and ward committee responsibilities. His leadership extends beyond teaching, encompassing student support, program enhancement, and strengthening research culture within the college. Dr. Sabei has participated in prominent scientific conferences and professional forums across the Middle East and the United States, presenting research in pharmaceutical sciences, nanomedicine, and drug-delivery innovations. His work has also been supported by multiple stages of institutional research funding, reflecting the significance and impact of his contributions. With a commitment to scientific innovation, health advancement, and community engagement, Dr. Fahad Y. Sabei continues to influence the future of pharmaceutical sciences and contribute meaningfully to the progression of medical research in Saudi Arabia and beyond.
Featured Publications
Bakkari, M. A., Ghoal, G., Sabei, F. Y., Safhi, A. Y., & Moni, S. S. (2025). Exploring Interleukin-6 inhibitor antibodies in combatting SARS-CoV-2 and its mutated variants: Challenges and future directions. Journal of Pharmacology and Pharmacotherapeutics. https://doi.org/10.1177/0976500X251316939
Fatima, I., Safhi, A. Y., Alsalhi, A., Hanbashi, A., Jali, A., Alsabei, H. M., Alshabrmi, F. M., & Sabei, F. Y. (2025). Identification and validation of key covalent inhibitors targeting lung cancer proteins through integrated in silico analysis. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152973
Madkhali, O. A., Moni, S. S., Almoshari, Y., Sabei, F. Y., & Safhi, A. Y. (2025). Dual role of CXCL10 in cancer progression: Implications for immunotherapy and targeted treatment. Cancer Biology & Therapy. https://doi.org/10.1080/15384047.2025.2538962
Akhtar, S., Shafeeq, S., Siddique, A. B., Sabei, F. Y., Safhi, A. Y., Ullah, S., Abbas, A., Hanbashi, A., Alshahi, H., Jali, A. M., et al. (2025). Facile synthesis of bimetallic Ag-Fe core–shell nanoparticles for the selective and efficient dehydrogenation of formic acid. Journal of Power Sources. https://doi.org/10.1016/j.jpowsour.2025.236919
Zoghebi, K., Sabei, F. Y., & Safhi, A. Y. (2024). Exploring the anti-cancer properties of Carissa carandas as a multi-targeted approach against breast cancer. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2024.2437548
Shakir, R., Hanif, S., Salawi, A., Arshad, R., Sarfraz, R. M., Irfan, M., Raza, S. A., Barkat, K., Sabei, F. Y., Almoshari, Y., et al. (2024). Correction: Shakir et al. Exorbitant drug loading of metformin and sitagliptin in mucoadhesive buccal tablet: In vitro and in vivo characterization in healthy volunteers (2022). Pharmaceuticals. https://doi.org/10.3390/ph17050556